Global Academy for Medical Education

Conferences Earn CME/CE

January 29 - February 5, 2022 • Virtual Event

March 17 - 19, 2022 • Virtual Event

May 5 - 6, 2022 • Hybrid Event

June 23 - 25, 2022 • Hybrid Event

There are no results under this Specialty.

There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.

Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma.

“Prevention is low cost, low risk, and effective.”